Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan;13(1):e70047.
doi: 10.1002/mgg3.70047.

Delineation of the Genetic Architecture and Clinical Polymorphism of 3q29 Duplication Syndrome: A Review of the Literature and a Report of Two Novel Patients With Single-Gene BDH1 Duplications

Affiliations
Review

Delineation of the Genetic Architecture and Clinical Polymorphism of 3q29 Duplication Syndrome: A Review of the Literature and a Report of Two Novel Patients With Single-Gene BDH1 Duplications

A A Kashevarova et al. Mol Genet Genomic Med. 2025 Jan.

Abstract

Background: Chromosome 3q29 duplication syndrome is a rare chromosomal disorder with a frequency of 1:5000 in patients with a neurodevelopmental phenotype. The syndrome is characterized by phenotypic polymorphism and reduced penetrance.

Methods: Patients were investigated by performing a cytogenetic analysis of GTG-banded metaphases, aCGH with the SurePrint G3 Human CGH Microarray 8×60K, qPCR, FISH, and WES.

Results: Here, we report five new patients with atypical duplications overlapping with the 3q29 duplication syndrome region and no other genetic findings. In two patients, duplications were found in the single BDH1 gene, a candidate gene for the 3q29 duplication phenotype. For the first time, we delineated and described the smallest minimal critical region, including the single BDH1 gene; in our patients, this region was associated with ASD, heart defects, biliary tract dysfunction, and obesity. The frequencies of the pathological phenotypes in duplication carriers reported in the literature were calculated and compared with those in patients with 3q29 deletions. Most of the phenotypes were observed in both groups but were significantly less common among individuals with 3q29 duplications. Mirrored phenotypes in patients with duplications and deletions included overweight and weight deficit. Schizophrenia, generalized anxiety disorder, and recurrent ear infections were unique phenotypes of patients carrying deletions.

Conclusion: Chromosome 3q29 duplication syndrome is characterized by a complex genetic architecture and clinical polymorphism.

Keywords: BDH1; 3q29 deletion syndrome; 3q29 duplication syndrome; minimal critical region; mirrored phenotypes; unique phenotypes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Molecular cytogenetic results and pedigree of Family 1. (A) aCGH profile of chromosome 3 in Patient 1.1. (B) Gene content of the duplicated 3q29 region (blue). (C) Pedigree of Family 1. (D) qPCR results obtained using primers for exon 16 of the LMLN gene. (E) qPCR results obtained with primers for exon 12 of the IQCG gene. X axis—control DNA and examined individuals; Y axis—fold change in the copy number of a DNA region compared with the control. GM, grandmother; M, mother; P, patient 1.1.
FIGURE 2
FIGURE 2
Molecular cytogenetic results and pedigree of Family 2. (A) aCGH profile of chromosome 3 in Patient 2.1. (B) Gene content of the duplicated 3q29 region (blue). (C) aCGH profile of chromosome 3 in Patient 2.2. (D) Pedigree of Family 2. (E) qPCR results obtained with primers for exon 2 of the LINC00885 gene. X axis—control DNA and examined individuals; Y axis—fold change in the copy number of a DNA region compared with the control. F, father; M, mother; P1, patient 2.1, P2, patient 2.2.
FIGURE 3
FIGURE 3
Molecular cytogenetic results and pedigree of Family 3. (A) aCGH profile of chromosome 3 in Patient 3.1. (B) Gene content of the duplicated 3q29 region (blue). (C) Pedigree of Family 3. (D) qPCR results obtained with primers for exon 5 of the BDH1 gene. X axis—control DNA and examined individuals; Y axis—fold change in the copy number of a DNA region compared with the control. F, father; M, mother; P, patient 3.1.
FIGURE 4
FIGURE 4
Molecular cytogenetic results and pedigree of Family 4. (A) aCGH profile of chromosome 3 in Patient 4.1. (B) Gene content of the duplicated 3q29 region (blue). (C) Pedigree of Family 4. (D) qPCR with primers for exon 5 of the BDH1 gene. X axis—control DNA and examined individuals; Y axis—fold change in the copy number of a DNA region compared with the control. F, father; M, mother; P, patient 4.1; S, sibling.
FIGURE 5
FIGURE 5
Map of 3q29 microduplications with minimal overlapping regions. MOR, minimal overlapping region.

Similar articles

References

    1. Aubert, G. , Martin O. J., Horton J. L., et al. 2016. “The Failing Heart Relies on Ketone Bodies as a Fuel.” Circulation 133, no. 8: 698–705. 10.1161/CIRCULATIONAHA.115.017355. - DOI - PMC - PubMed
    1. Ballif, B. C. , Theisen A., Coppinger J., et al. 2008. “Expanding the Clinical Phenotype of the 3q29 Microdeletion Syndrome and Characterization of the Reciprocal Microduplication.” Molecular Cytogenetics 1: 8. 10.1186/1755-8166-1-8. - DOI - PMC - PubMed
    1. Bauleo, A. , Pace V., Montesanto A., et al. 2023. “3q29 Microduplication Syndrome: New Evidence for the Refinement of the Critical Region.” Molecular Genetics & Genomic Medicine 11, no. 4: e2130. 10.1002/mgg3.2130. - DOI - PMC - PubMed
    1. Bedi, K. C., Jr. , Snyder N. W., Brandimarto J., et al. 2016. “Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure.” Circulation 133, no. 8: 706–716. 10.1161/CIRCULATIONAHA.115.017545. - DOI - PMC - PubMed
    1. Biamino, E. , Di Gregorio E., Belligni E. F., et al. 2015. “A Novel 3q29 Deletion Associated With Autism, Intellectual Disability, Psychiatric Disorders, and Obesity.” American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 171B, no. 2: 290–299. 10.1002/ajmg.b.32406. - DOI - PubMed

Substances

LinkOut - more resources